Virus variant–specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022

OBJECTIVES: Antigen rapid diagnostic tests (RDTs) for SARS coronavirus 2 (SARS-CoV-2) are quick, widely available, and inexpensive. Consequently, RDTs have been established as an alternative and additional diagnostic strategy to quantitative reverse transcription polymerase chain reaction (RT-qPCR)....

Descripción completa

Detalles Bibliográficos
Autores principales: Wagenhäuser, Isabell, Knies, Kerstin, Hofmann, Daniela, Rauschenberger, Vera, Eisenmann, Michael, Reusch, Julia, Gabel, Alexander, Flemming, Sven, Andres, Oliver, Petri, Nils, Topp, Max S., Papsdorf, Michael, McDonogh, Miriam, Verma-Führing, Raoul, Scherzad, Agmal, Zeller, Daniel, Böhm, Hartmut, Gesierich, Anja, Seitz, Anna K., Kiderlen, Michael, Gawlik, Micha, Taurines, Regina, Wurmb, Thomas, Ernestus, Ralf-Ingo, Forster, Johannes, Weismann, Dirk, Weißbrich, Benedikt, Dölken, Lars, Liese, Johannes, Kaderali, Lars, Kurzai, Oliver, Vogel, Ulrich, Krone, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398563/
https://www.ncbi.nlm.nih.gov/pubmed/36028089
http://dx.doi.org/10.1016/j.cmi.2022.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398563/
https://www.ncbi.nlm.nih.gov/pubmed/36028089
http://dx.doi.org/10.1016/j.cmi.2022.08.006

Ejemplares similares